Corcept Therapeutics
CORT
CORT
58 hedge funds and large institutions have $56.7M invested in Corcept Therapeutics in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
10% less capital invested
Capital invested by funds: $62.8M → $56.7M (-$6.02M)
Holders
58
Holding in Top 10
1
Calls
$34K
Puts
–
Top Buyers
| 1 | +$278K | |
| 2 | +$127K | |
| 3 | +$79.5K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$70.2K |
| 5 |
ISL
Ingalls & Snyder LLC
New York
|
+$55.8K |
Top Sellers
| 1 | -$1.14M | |
| 2 | -$282K | |
| 3 | -$253K | |
| 4 |
U
UBS
Zurich,
Switzerland
|
-$72.7K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$72K |